1009094-73-8 |
3-AMINO-5-(TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOIC ACID |
3-aMino-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzoic acid |
C13H18BNO4 |
10091-01-7 |
|
6-(2-Methoxy-4,5-methylenedioxyphenyl)-7H-furo[3,2-g][1]benzopyran-7-one |
C19H12O6 |
10091-02-8 |
|
6,7-Dihydro-6-(6-methoxy-1,3-benzodioxol-5-yl)-5H-furo[3,2-g][1]benzopyran-5-one |
C19H14O6 |
10091-84-6 |
|
3-(3-Methyl-2-butenyl)-3H-purin-6-amine |
C10H13N5 |
100910-66-5 |
5-甲基吡啶-3-甲醛 |
5-Methylpyridine-3-carboxaldehyde |
C7H7NO |
100910-81-4 |
|
2,4-diethoxypyrimidin-5-amine |
C8H13N3O2 |
100910-90-5 |
|
1,2-Hexanediol, 4-methyl |
C7H16O2 |
1009102-44-6 |
1-(4-氯苯基)环丙胺盐酸盐 |
Cyclopropanamine, 1-(4-chlorophenyl)-, hydrochloride (1:1) |
|
1009104-85-1 |
Smad3 Inhibitor, SIS3 |
Smad3 Inhibitor, SIS3 |
C28H27N3O3 |
1009107-27-0 |
达卡他韦杂质 02 |
Daclatasvir Impurity 2 |
C40H50N8O6 |
100911-07-7 |
|
Nicotinamide, 1,4,5,6-tetrahydro-N-methyl- (6CI) |
C7H12N2O |
100911-26-0 |
|
1-Pyrroline-5-carboxylicacid,3-isopropyl-(6CI) |
C8H13NO2 |
100911-27-1 |
|
3-Pyrroline-2-carboxylicacid,4-isopropyl-(6CI) |
C8H13NO2 |
100911-49-7 |
1-(2-氨乙基)哌啶二盐酸盐 |
N-(2-Aminoethyl)piperidine dihydrochloride |
C7H18Cl2N2 |
100911-51-1 |
|
Heptanoic acid, 6-hydroxy-, hydrazide |
C7H16N2O2 |
100911-67-9 |
|
1-amino-2-methylhexan-2-ol |
C7H17NO |
1009113-58-9 |
Daclatasvir Impurity E |
Daclatasvir Impurity E |
C42H54N8O6 |
1009113-62-5 |
C,C'-bis(1-Methylethyl) Ester N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic Acid, |
|
|
1009117-26-3 |
达拉他韦杂质 |
Daclatasvir Impurity D |
C40H50N8O6 |
1009117-28-5 |
达卡它韦杂质 |
Daclatasvir Impurity 5 (SRSS-Isomer) |
C40H50N8O6 |
1009117-94-5 |
Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate |
Daclatasvir impurity 7/Daclatasvir RRSS Isomer/dimethyl (2R,2'S)-1,1'-((2R,2'R)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate |
C40H50N8O6 |
1009119-17-8 |
tert-butyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate |
tert-butyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate |
C46H62N8O6 |
1009119-18-9 |
Daclatasvir Di-Descarbamate Impurity |
Daclatasvir Di-Descarbamate Impurity |
C36H46N8O2 |
1009119-59-8 |
|
2-((R)-pyrrolidin-2-yl)-5-(4'-(2-((R)-pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazole |
C26H28N6 |
1009119-64-5 |
达卡他韦 |
Daclatasvir (BMS-790052) |
C40H50N8O6 |
1009119-65-6 |
达卡他韦二盐酸盐 |
Daclatasvir dihydrochloride |
C40H50N8O6.2<(HCl)> |
1009119-83-8 |
1H-咪唑, 5,5'-[1,1'-联苯]-4,4'-双[2-(2S)-2-吡咯烷盐酸盐 |
HCV-IN-29 |
C26H32Cl4N6 |
100912-15-0 |
|
3-METHYL-1-TRIDECYN-3-OL |
C14H26O |
1009120-00-6 |
|
2H-1,3-Oxazine-4-carboxylic acid, tetrahydro-2-oxo-, (4S) |
C5H7NO4 |
1009120-03-9 |
(S)-2-(甲氧羰基氨基)-2-(四氢-2H-吡喃-4-基)乙酸 |
(S)-2-(Methoxycarbonylamino)-2-(tetrahydro-2H-pyran-4-yl)ethanoic acid |
C9H15NO5 |
1009120-05-1 |
2-((甲氧基羰基)氨基)-2-(氧杂环丁烷-3-基)乙酸 |
2-(Methoxycarbonylamino)-2-(oxetan-3-yl)acetic acid |
C7H11NO5 |
100913-51-7 |
|
Dodecanoic acid, 12-(dimethylamino)-10-oxo |
C14H27NO3 |
100914-20-3 |
6,8-二氯黄酮 |
6,8-DICHLOROFLAVONE |
C15H8Cl2O2 |
100914-35-0 |
2-(4-硝基-1,3-二氧代-异吲哚-2-基)苯甲酸 |
2-(4-nitro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzoic acid |
C15H8N2O6 |
100915-04-6 |
|
benzoyl-r-mandelic acid |
C15H12O4 |
100915-81-9 |
|
7-Octenoic acid, 5-(chlorocarbonyl)-2-(2-propen-1-yl)-, ethyl ester |
C14H21ClO3 |
100915-92-2 |
TYR-SER-GLU-GLU-PRO-PRO-ILE-SER-LEU-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-GLU-VAL-LEU-GLU-MET-ALA-ARG-ALA-GLU-GLN-LEU-ALA-GLN-GLN-ALA-HIS-SER-ASN-ARG-LYS-LEU-MET-GLU-ILE-ILE-NH2: YSEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
TYR-CORTICOTROPIN RELEASING FACTOR HUMAN, RAT |
|
100915-96-6 |
安博莱特 MB-150树脂 |
AMBERLITE MB-150 |
NULL |
100915-97-7 |
混合床树脂 氢和氢氧型 |
MIXED BED RESIN TMD-8 |
|
1009155-76-3 |
|
methyl 2-(1-((3-methoxyphenyl)carbamothioyl)-3-oxodecahydroquinoxalin-2-yl)acetate |
C19H25N3O4S |
1009157-55-4 |
1-(2,5-dimethylphenyl)-3-[2-(1H-indol-3-yl)ethylamino]pyrrolidine-2,5-dione |
|
C22H23N3O2 |
100916-00-5 |
|
2-Butenedioicacid(2E)-,polymerwith2,5-furandione,2,2'-oxybis[ethanol]and3a,4,7,7a-tetrahydro-4,7-methano-1H-indene |
C22H28O10 |
100916-01-6 |
|
1,3-Benzenedicarboxylicacid,polymerwith1,4-butanediol,4,4'-diisocyanato-3,3'-dimethyl-1,1'-biphenyl,1,6-hexanediol,.alpha.-hydro-.omega.-hydroxypoly(oxy-1,4-butanediyl),nonanedioicacidand2,2'-[1,4-phenylenebis(oxy)]bis[ethanol] |
<(C16H12N2O2.C10H14O4.C9H16O4.C8H6O4.C6H14O2.C4H10O2.<(C4H8O)>nH2O)>x |
1009162-69-9 |
|
4,8-dimethyl-2-oxo-2H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)butanoate |
C20H25NO6 |
1009162-76-8 |
|
2-(3-METHYL-2,4-DIOXO-THIAZOLIDIN-5-YLAMINO)-BENZOIC ACID |
C11H10N2O4S |
1009163-08-9 |
[3-(4-fluorophenyl)-2-methyl-4-oxochromen-7-yl] 2-[(4-methylphenyl)sulfonylamino]-3-phenylpropanoate |
|
C32H26FNO6S |
1009164-25-3 |
|
Benzeneacetamide, N-[4-chloro-2-(trifluoromethyl)phenyl]-α-[[2-(dimethylamino)ethyl]amino]- |
C19H21ClF3N3O |
1009165-36-9 |
|
2-(((1-benzyl-5-oxo-2-thioxoimidazolidin-4-yl)methyl)thio)acetic acid |
C13H14N2O3S2 |
1009165-91-6 |
|
1-(benzylcarbamothioyl)-5-hydroxypyrrolidine-2-carboxylic acid |
C13H16N2O3S |
1009165-99-4 |
|
N-(2,5-dichlorophenyl)-2-(3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetamide |
C16H13Cl2N3O2 |